Market Overview

UPDATE: Sterne Agee Reiterates Neutral Rating, Raises PT on ICON plc

Share:
Related ICLR
Earnings Scheduled For February 25, 2015
Top 4 NASDAQ Stocks In The Medical Laboratories & Research Industry With The Highest EPS

In a report published Monday, Sterne Agee Group reiterated its Neutral rating on ICON plc (NASDAQ: ICLR), and slightly raised its price target from $24.00 to $25.00.

Sterne Agee noted, “Not unlike our caution on PRXL, we must question ICLR's ability to provide accurate forecasts. However, ICLR's forecasting and cost management skills have proven quite conservative over the years. ICLR is projecting EBIT margins to return to levels achieved a few years back, while PRXL is projecting 2-3 year margins never achieved by the company. We use a 15x multiple on our CY14 EPS estimate to arrive at a $25 price target, which compares to an average 17x over the past 10 years.”

ICON plc closed on Friday at $28.29.

Latest Ratings for ICLR

DateFirmActionFromTo
Mar 2015SunTrust Robinson HumphreyMaintainsBuy
Feb 2015JefferiesMaintainsBuy
Jan 2015JefferiesMaintainsBuy

View More Analyst Ratings for ICLR
View the Latest Analyst Ratings

Posted-In: Sterne Agee GroupAnalyst Color Price Target Analyst Ratings

 

Related Articles (ICLR)

Around the Web, We're Loving...